NCT02981498View on ClinicalTrials.gov

Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

Hepatic arterial infusion chemotherapy

administration of Oxaliplatin , fluorouracil, and leucovorin via the tumor feeding arteries

DRUG

Folfox Protocol

Oxaliplatin , fluorouracil, and leucovorin

Trial Locations (1)

510060

Cancer Center, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT02981498 - Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter